Life Extension Magazine December 2006
The Deadly Connection Between Diabetes and Alzheimer's
By Edward R. Rosick, DO, MPH, DABHM
Effects of Diet in Maintaining Healthy Blood Sugar
Now that diabetes appears to be associated with Alzheimer's, it is imperative to take action to protect against this burgeoning epidemic. The first two steps are ones that almost everyone can implement: eat a healthy diet and exercise regularly.
The typical modern American diet, with its preponderance of meats, trans-fatty acids, and sugar, significantly increases the prevalence of insulin resistance and type II diabetes.15 Additionally, the American diet is typically low in healthful monounsaturated and omega-3 polyunsaturated fats, which are critical to optimal health and can also help improve insulin resistance.
Trans fats, found in hydrogenated vegetable oils and hard-stick margarine, worsen insulin sensitivity. By contrast, monounsaturated fats, such as those in olive oil, almonds, and avocados, improve insulin sensitivity.16 Similarly, studies suggest that minimizing saturated fats, found in high amounts in animal products such as red meat and whole milk, may help to lessen one's risk for type II diabetes.16
Omega-3 fatty acids from fish oil, such as EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), may be helpful in maintaining healthy glucose levels and optimal insulin action. Studies suggest that intake of omega-3 fats from fish oil is associated with accelerated glucose uptake and maintenance of normal glucose metabolism. Additionally, fish oil enhances insulin secretion from the cells of the pancreas.17
A healthy diet may thus help guard against diabetes and, by association, Alzheimer's disease.
Regular Exercise Improves Insulin Resistance
In addition to eating a diet that is low in saturated fat and sugar, high in monounsaturated fats, and rich in vegetables, fruits, and fiber, getting regular exercise is another vitally important way to both prevent and correct insulin resistance.
Exercise can improve insulin sensitivity in skeletal muscle and fat tissue, and has been shown to consistently reduce insulin and fasting blood sugar levels.18 Moreover, recent studies demonstrate that a healthy diet and regular exercise can improve cognition in people who are at high risk for insulin resistance and diabetes.19 In one such study, researchers showed that a group of adults with insulin resistance who followed a basic American Heart Association diet and exercised three times a week on a treadmill for one hour had increased memory retention compared to adults in a control group. The authors concluded that exercise and good nutrition may facilitate improvements in memory for older adults who are at high risk for type II diabetes. These findings may also have implications for guarding against the development of impaired memory and Alzheimer's.
Magnesium, Chromium Fight Insulin Resistance and Diabetes
Magnesium and chromium are two important minerals that have significant effects on insulin resistance and type II diabetes.
Multiple studies attest to the importance of magnesium supplementation, as exemplified by a controlled, randomized, double-blind trial published in 2003 in the journal Diabetes Care.20 In this study, 63 people with type II diabetes were randomly assigned to receive either 2.5 grams of magnesium or a placebo daily for 16 weeks. At the end of the study period, scientists found that those who took the magnesium supplements had statistically significant improvements in insulin sensitivity, indicating better metabolic control of their diabetes.
Chromium has also been shown to be safe and effective in the management of patients with insulin resistance and type II diabetes. In a study of 180 men and women with type II diabetes, those who took 200-1000 mcg of chromium daily showed numerous improvements in blood sugar metabolism. These beneficial changes included significant decreases in levels of fasting glucose, fasting insulin, and two-hour insulin.21
By improving insulin sensitivity, magnesium and chromium may help prevent conditions associated with insulin resistance, including inflammation, diabetes, and Alzheimer's.
Lipoic Acid Provides Powerful Antioxidant Protection
Lipoic acid, a powerful antioxidant, is also known for its ability to improve insulin sensitivity. In one study, 74 patients with type II diabetes were randomly assigned to receive either a placebo or 600, 1200, or 1800 mg a day of alpha-lipoic acid.22 After four weeks, those receiving alpha-lipoic acid supplements had statistically improved insulin sensitively. All three doses of alpha-lipoic acid were effective in improving insulin sensitivity.
Studies show that alpha-lipoic acid also helps protect help the brain against damage caused by free-radical-induced oxidative stress, which could have important implications for its potential role in protecting against Alzheimer's disease.23,24
By restoring insulin sensitivity and protecting the brain against oxidative stress, alpha-lipoic acid shows promise as a weapon against both diabetes and Alzheimer's.
Cinnamon Promotes Healthy Blood Sugar Metabolism
Cinnamon, a common spice used the world over, has shown value in managing insulin resistance and type II diabetes in both laboratory and human studies. Cinnamon contains many beneficial chemical constituents such as flavonoids that act as potent antioxidants.
A recent randomized, placebo-controlled study published in Diabetes Care examined the effects of supplementing with 1, 3, or 6 grams of cinnamon daily in 60 middle-aged men and women with type II diabetes.25 At the end of the 40-day study, the subjects who took cinnamon at all three dosages significantly decreased their fasting serum glucose, triglycerides, total cholesterol, and low-density lipoprotein (LDL).
Cinnamon's ability to promote healthy blood sugar metabolism suggests a therapeutic role for this spice in preventing and managing insulin resistance and diabetes. Its efficacy in supporting optimal blood sugar levels further suggests a potential role in averting the dangers of Alzheimer's disease.
Carnosine Counters Damaging Effects of Glycation
Growing evidence demonstrating the damaging effects of advanced glycation end products—and the strong association between AGEs, free radicals, and crippling diseases such as diabetes and Alzheimer's—underscore the need to protect against these destructive chemicals. One way to do this is by supplementing with carnosine.
Carnosine, a natural compound made up of the amino acids beta-alanine and L-histidine, is present in high concentrations in brain and skeletal muscle tissue. Scientists have shown that carnosine can inhibit free-radical-induced cellular damage,26 delay the impairment of eyesight associated with aging,27 and even extend the life span of mammals.28 Carnosine confers these beneficial effects through its ability to prevent the formation of advanced glycation end products.
Experimental studies have shown that carnosine specifically protects the brain against damage induced by free radicals and AGEs, a finding that may have important implications for the prevention and treatment of Alzheimer's disease.29-31 One study showed that carnosine protects the brain against the toxic effects of malondialdehyde, an AGE-like compound that is formed when lipids react with free radicals.30 Using cultured rat brain cells, researchers demonstrated that carnosine protects brain cells from malondialdehyde-induced toxicity and prevents this compound from dangerously altering proteins in the body.
A recent article examined carnosine's protective effects against beta amyloid.31 Using rat brain cells in the laboratory, researchers showed that introducing beta amyloid to the cultures produced measurable toxic effects. The researchers then demonstrated that damage to the brain cells could be substantially mitigated by adding carnosine to the mixture, leading them to conclude that carnosine protects brain cells by quenching oxidative stress and preventing damaging glycation reactions—both of which are implicated in the neuronal cell damage characteristic of Alzheimer's disease. Carnosine therefore appears be a useful therapeutic in protecting neurons against the toxic effects of beta amyloid.
By inhibiting oxidative stress and AGE formation, carnosine may be a powerful weapon against both diabetes and Alzheimer's disease.
Growing scientific evidence suggests that diabetes and Alzheimer's disease—two epidemic yet seemingly different disorders that threaten the health of tens of millions of Americans—may not be so dissimilar after all. These two apparently divergent conditions share a striking number of biochemical similarities, and scientists increasingly believe that the two diseases may be closed related.
Given the growing prevalence of insulin resistance and diabetes in the United States and other Western nations, this news has far-reaching implications. Fortunately, substantial research demonstrates that a program incorporating dietary modifications, regular exercise, and scientifically substantiated nutritional supplements can help aging adults to greatly lessen their risk for the twin afflictions of diabetes and Alzheimer's disease.
Edward R. Rosick, DO, MPH, DABHM, is a board-certified physician in preventive and holistic medicine, and assistant professor of medicine at Michigan State University.
1. Available at: http://diabetes.niddk.nih.gov/dm/pubs/statistics/index.htm. Accessed September 29, 2006.
2. Ramasamy R, Vannucci SJ, Yan SS, et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology. 2005 Jul;15(7):16R-28R.
3. Opara EC. Oxidative stress, micronutrients, diabetes mellitus and its complications. J R Soc Health. 2002 Mar;122(1):28-34.
4. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006 Apr 13;440(7086):944-8.
5. Available at: http://www.alz.org/AboutAD/statistics.asp. Accessed September 29, 2006.
6. Grundman M, Thal LJ. Treatment of Alzheimer's disease: rationale and strategies. Neurol Clin. 2000 Nov;18(4):807-28.
7. Mayeux R, Sano M. Treatment of Alzheimer's disease. N Engl J Med. 1999 Nov 25;341(22):1670-9.
8. Wenk GL. Neuropathological changes in Alzheimer's disease: potential targets for treatment. J Clin Psychiatry. 2006;67 Suppl 3:3-7;quiz 23.
9. Masters CL, Cappai R, Barnham KJ, Villemagne VL. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeteutics. J Neurochem. 2006 Jun;97(6):1700-25.
10. Moreira PI, Smith MA, Zhu X, et al. Oxidative stress and neurodegeneration. Ann NY Acad Sci. 2005 Jun;1043:545-52.
11. Available at: http://www.alz.org/icad/newsreleases/071606_noon_diabtesandad.asp. Accessed September 29, 2006.
12. Ott A, Stolk RP, van HF, et al. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology. 1999 Dec 10;53(9):1937-42.
13. Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology. 2004 Oct 12;63(7):1187-92.
14. Fishel MA, Watson GS, Montine TJ, et al. Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. Arch Neurol. 2005 Oct;62(10):1539-44.
15. Available at: http://www.webmd.com/content/article/5/1680_51079.htm. Accessed September 29, 2006.
16. Rivellese AA, Lilli S. Quality of dietary fatty acids, insulin sensitivity and type 2 diabetes. Biomed Pharmacother. 2003 Mar;57(2):84-7.
17. [No authors listed]. Monograph. Fish oil. Altern Med Rev. 2000 Dec;5(6):576-80.
18. Kelly GS. Insulin resistance: lifestyle and nutritional interventions. Altern Med Rev. 2000 Apr;5(2):109-32.
19. Watson GS, Reger MA, Baker LD, et al. Effects of exercise and nutrition on memory in Japanese Americans with impaired glucose tolerance. Diabetes Care. 2006 Jan;29(1):135-6.
20. Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003 Apr;26(4):1147-52.
21. Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997 Nov;46(11):1786-91.
22. Jacob S, Ruus P, Hermann R, et al. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med. 1999 Aug;27(3-4):309-14.
23. Arivazhagan P, Panneerselvam C. Alpha-lipoic acid increases Na+K+ATPase activity and reduces lipofuscin accumulation in discrete brain regions of aged rats. Ann N Y Acad Sci. 2004 Jun;1019:350-4.
24. Lovell MA, Xie C, Xiong S, Markesbery WR. Protection against amyloid beta peptide and iron/hydrogen peroxide toxicity by alpha lipoic acid. J Alzheimers Dis. 2003 Jun;5(3):229-39.
25. Khan A, Safdar M, li Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003 Dec;26(12):3215-8.
26. Boldyrev AA, Stvolinsky SL, Tyulina OV, et al. Biochemical and physiological evidence that carnosine is an endogenous neuroprotector against free radicals. Cell Mol Neurobiol. 1997 Apr;17(2):259-271.
27. Wang AM, Ma C, Xie ZH, Shen F. Use of carnosine as a natural anti-senescence drug for human beings. Biochemistry (Mosc.). 2000 Jul;65(7):869-71.
28. Stvolinskii SL, Fedorova TN, Yuneva MO, Boldyrev AA. Protective effect of carnosine on Cu,Zn-superoxide dismutase during impaired oxidative metabolism in the brain in vivo. Bull Exp Biol Med. 2003 Feb;135(2):130-2.
29. Dukic-Stefanovic S, Schinzel R, Riederer P, Munch G. AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs? Biogerontology. 2001;2(1):19-34.
30. Hipkiss AR, Preston JE, Himswoth DT, Worthington VC, Abbot NJ. Protective effects of carnosine against malondialdehyde-induced toxicity towards cultured rat brain endothelial cells. Neurosci Lett. 1997 Dec 5;238(3):135-8.
31. Preston JE, Hipkiss AR, Himsworth DT, Romero IA, Abbott JN. Toxic effects of beta-amyloid(25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine. Neurosci Lett. 1998 Feb 13;242(2):105-8.
32. Singh S, Khar A. Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem. 2006 May;6(3):259-70.
33. Pari L, Murugan P. Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats. J Basic Clin Physiol Pharmacol. 2005;16(4):257-74.
34. Jain SK, Rains J, Jones K. Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels. Free Radic Biol Med. 2006 Jul 1;41(1):92-6.
35. Ringman JM, Frautschy SA, Cole GM, Masterman DL, Cummings JL. A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res. 2005 Apr;2(2):131-6.
36. Takeuchi M, Kikuchi S, Sasaki N, et al. Involvement of advanced glycation end-products (AGEs) in Alzheimer's disease. Curr Alzheimer Res. 2004 Feb;1(1):39-46.
37. Furber JD. Extracellular glycation crosslinks: prospects for removal. Rejuvenation Res. 2006 Summer;9(2):274-8.
38. Munch G, Kuhla B. Luth HJ, Arendt T, Robinson SR. Anti-AGEing defenses against Alzheimer's disease. Biochem Soc Trans. 2003 Dec;31(Pt 6):1397-9.
39. Peppa M, Uribarri J, Vlassara H. Glucose, advanced glycation end products, and diabetes complications: what is new and what works. Clinical Diabetes. 2003;21:186-7.
40. McCarty MF. The low-AGE content of low-fat vegan diets could benefit diabetics - though concurrent taurine supplementation may be needed to minimize endogenous AGE production. Med Hypotheses. 2005;64(2):394-8.
41. Qian P, Cheng S, Guo J, Niu Y. Effects of vitamin E and vitamin C on nonenzymatic glycation and peroxidation in experimental diabetic rats. Wei Sheng Yan Jiu. 2000 Jul;29(4):226-8.
42. Thomas MC, Baynes JW, Thorpe SR, Cooper MF. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr Drug Targets. 2005 Jun;6(4):453-74.
43. Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J Alzheimers Dis. 2005 Dec;8(3):247-68.
44. de la Monte SM, Tong M, Lester-Coll N, Plater M Jr, Wands JR. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: Relevance to Alzheimer's disease. J Alzheimers Dis. 2006 Nov;10(1):89-109.